Biotechnology - , New York, United States
Immunic, Inc. (Nasdaq: IMUX) is a clinical-stage biopharmaceutical company with a pipeline of selective oral immunology therapies focused on treating chronic inflammatory and autoimmune diseases.
Outlook
Nginx
WordPress.org
Google Font API
Mobile Friendly
Vimeo